Concordia Healthcare $1.2 billion acquisition of Covis Pharma assets

9/4/2015

Private acquisition

Value:

$ 1.2 billion

Status:

Completed

Date:

9/4/2015

Overview:

Concordia Healthcare acquired Covis Pharma assets in a transaction worth $1.2 billion.
These assets included cardiovascular, central nervous system, oncology and acute care products.

Rani Mehta - Journalist

Jurisdictions:

Canada
United States
France

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:

Fasken

Party: Concordia Healthcare (Acquirer)

Lowenstein Sandler

Party: Covis Pharma (Target)

Lawyers: Jeffrey Shapiro, Peter Ehrenberg, Robert Minion, Sam Khan

Sullivan & Cromwell

Party: Concordia Healthcare (Acquirer)

Lawyer: Matthew Hurd

Related deals